Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Soy infant formula and phytoestrogens.

P G Tuohy1

  • 1Ministry of Health, Wellington, New Zealand. pat_tuohy@moh.govt.nz

Journal of Paediatrics and Child Health
|August 16, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethnic differences in parent/infant co-sleeping practices in New Zealand.

The New Zealand medical journal·2000
Same author

Soy formulas and the effects of isoflavones on the thyroid.

The New Zealand medical journal·2000
Same author

Immunisation coverage in New Zealand.

The New Zealand medical journal·2000
Same author

Risk factors for sudden infant death syndrome following the prevention campaign in New Zealand: a prospective study.

Pediatrics·1997
Same author

Pertussis vaccination.

The New Zealand medical journal·1996
Same author

Sociodemographic factors associated with sleeping position and location.

Archives of disease in childhood·1993

Soy infant formula contains high levels of phytoestrogens, potentially impacting infant health. More research is needed to understand the risks versus benefits of early exposure to these compounds.

Area of Science:

  • Endocrinology
  • Developmental Pediatrics
  • Nutritional Science

Background:

  • Soy infant formula is rich in isoflavones (genistein, daidzein), known as phytoestrogens due to their structural similarity to estrogen.
  • Infants fed soy formula exhibit significantly higher circulating isoflavone levels than adults on high-soy diets, raising questions about developmental impact.
  • Existing research on the risks and benefits of soy phytoestrogens presents conflicting findings, with limited data specific to human neonates.

Purpose of the Study:

  • To review the current understanding of soy phytoestrogen exposure in infants.
  • To highlight the discrepancies between potential benefits and emerging concerns regarding adverse effects.
  • To emphasize the need for a precautionary approach due to potential developmental impacts.

Main Methods:

Related Experiment Videos

  • Literature review of studies on soy isoflavones, phytoestrogens, and infant health.
  • Analysis of existing research on physiological effects in adults and experimental findings in animals.
  • Assessment of the gap in scientific knowledge regarding human neonatal exposure.

Main Results:

  • Infants consuming soy formula are exposed to high levels of isoflavones, exceeding those known to cause physiological effects in adults.
  • While some studies suggest protective effects against cancer and heart disease, recent animal research indicates potential adverse effects on reproduction, immunity, and thyroid function.
  • There is a significant lack of robust scientific data quantifying the risks associated with soy phytoestrogen consumption in human neonates.

Conclusions:

  • The safety of soy infant formula for neonates remains inadequately established due to limited human data.
  • Emerging evidence from animal studies suggests potential risks that warrant caution.
  • A precautionary principle should guide the use of soy formula in infants, given the potential for developmental effects from pharmacologically active compounds.